New Zealand King Salmon Investments Limited (NZE:NZK)

Intra-Cellular Therapies Income Statement

Financials in millions NZD. Fiscal year is February - January.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Revenue	210.99	187.11	167.13	174.53	163.27
Revenue Growth (YoY)	12.77%	11.95%	-4.24%	6.90%	5.10%
Cost of Revenue	165.63	128.05	136.51	161.79	139
Gross Profit	45.37	59.05	30.62	12.74	24.26
Selling, General & Admin	30.61	26.84	26.56	27.33	27.11
Other Operating Expenses	1.92	0.87	0.93	1.26	1.52
Operating Expenses	32.53	27.71	35.4	38.71	38.86
Operating Income	12.84	31.34	-4.78	-25.97	-14.6
Interest Expense	-0.58	-0.31	-1.05	-1.72	-1.6
Interest & Investment Income	1.47	1.05	0.34	0.02	0.01
Currency Exchange Gain (Loss)	4.56	6.73	7.78	-	-
Other Non Operating Income (Expenses)	0.88	1.23	0.35	-0.53	0.21
EBT Excluding Unusual Items	19.16	40.04	2.64	-28.2	-15.98
Impairment of Goodwill	-	-	-	-39.26	-
Gain (Loss) on Sale of Assets	-0.06	0.03	-0.02	-0.14	-0
Asset Writedown	-	-	-0.51	-20	-
Pretax Income	19.09	40.06	2.11	-87.59	-15.99
Income Tax Expense	5.74	11.61	0.22	-14.39	-3.85
Net Income	13.36	28.45	1.89	-73.2	-12.14
Net Income to Common	13.36	28.45	1.89	-73.2	-12.14
Net Income Growth	-53.05%	1404.60%	-	-	-
Shares Outstanding (Basic)	538	541	432	139	139
Shares Outstanding (Diluted)	538	541	432	139	139
Shares Change (YoY)	-0.56%	25.44%	210.52%	0.01%	-
EPS (Basic)	0.02	0.05	0.00	-0.53	-0.09
EPS (Diluted)	0.02	0.05	0.00	-0.53	-0.09
EPS Growth	-60.00%	1041.55%	-	-	-
Free Cash Flow	27.72	7.16	5.92	-3.29	-9.8
Free Cash Flow Per Share	0.05	0.01	0.01	-0.02	-0.07
Gross Margin	21.50%	31.56%	18.32%	7.30%	14.86%
Operating Margin	6.08%	16.75%	-2.86%	-14.88%	-8.94%
Profit Margin	6.33%	15.21%	1.13%	-41.94%	-7.43%
Free Cash Flow Margin	13.14%	3.83%	3.54%	-1.88%	-6.00%
EBITDA	18.94	37.3	1.15	-18.1	-6.54
EBITDA Margin	8.98%	19.94%	0.69%	-10.37%	-4.01%
D&A For EBITDA	6.11	5.96	5.93	7.87	8.06
EBIT	12.84	31.34	-4.78	-25.97	-14.6
EBIT Margin	6.08%	16.75%	-2.86%	-14.88%	-8.94%
Effective Tax Rate	30.04%	28.98%	10.55%	-	-

Updated Sep 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.